Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
53.24
-0.41 (-0.76%)
At close: May 22, 2026, 4:00 PM EDT
54.29
+1.05 (1.97%)
After-hours: May 22, 2026, 7:07 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $4.1 billion as of May 22, 2026. Its market cap has increased by 110.08% in one year.
Market Cap
4.10B
Enterprise Value
3.64B
1-Year Change
110.08%
Ranking
Category
Stock Price
$53.24
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $914.40M to $4.10B, an increase of 347.96%. That is a compound annual growth rate of 20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 4.10B | 31.01% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
| May 24, 2018 | 914.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantheus Holdings | 6.71B |
| Alkermes | 6.13B |
| Hims & Hers Health | 5.50B |
| Liquidia | 5.42B |
| Amneal Pharmaceuticals | 3.96B |
| Supernus Pharmaceuticals | 2.80B |
| Prestige Consumer Healthcare | 2.27B |
| BioCryst Pharmaceuticals | 2.11B |